Information:
Fel:
ID
34317
Beskrivning
Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT01352416
Länk
https://clinicaltrials.gov/show/NCT01352416
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Heart; Dysfunction Postoperative, Cardiac Surgery NCT01352416
Eligibility Heart; Dysfunction Postoperative, Cardiac Surgery NCT01352416
- StudyEvent: Eligibility
Similar models
Eligibility Heart; Dysfunction Postoperative, Cardiac Surgery NCT01352416
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
indications for cardiac surgery (cabg, valve surgery or cabg and valve surgery, able to provide informed consent.
boolean
ID.2
Item
documented atrial fibrillation within the previous 3 months
boolean
ID.3
Item
ongoing therapy with suppressive antiarrhythmic drugs
boolean
ID.4
Item
patient currently on digoxin
boolean
ID.5
Item
emergent surgery
boolean
ID.6
Item
patient receiving hemodialysis
boolean
ID.7
Item
concomitant use of ketoconazole, diltiazem, verapamil
boolean
ID.8
Item
known tolerance or hypersensitivity to ranolazine
boolean
ID.9
Item
pregnant individuals
boolean
ID.10
Item
maze procedure performed during concurrent cardiac surgery
boolean